{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:33:21Z","timestamp":1776692001311,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.lrr.2023.100372","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:31:47Z","timestamp":1685187107000},"page":"100372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Gray zone lymphoma: A case report and comprehensive review of literature"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-5796","authenticated-orcid":false,"given":"Dariusz","family":"Uczkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay","family":"Dimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2023.100372_bib0001","unstructured":"Lymphoma - statpearls NCBI bookshelf. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560826\/. Accessed October 5, 2022."},{"key":"10.1016\/j.lrr.2023.100372_bib0002","doi-asserted-by":"crossref","unstructured":"Mugnaini E.N., Ghosh N. Lymphoma. Primary Care. 2016;43(4):661\u2013675. doi:10.1016\/j.pop.2016.07.012.","DOI":"10.1016\/j.pop.2016.07.012"},{"issue":"8","key":"10.1016\/j.lrr.2023.100372_bib0003","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ijc.21716","article-title":"Molecular biology of Hodgkin's and Reed\/Sternberg cells in Hodgkin's lymphoma","volume":"118","author":"Br\u00e4uninger","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.lrr.2023.100372_bib0004","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biocel.2003.10.025","article-title":"The Hodgkin and reed\/Sternberg cell","volume":"37","author":"K\u00fcppers","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9844","key":"10.1016\/j.lrr.2023.100372_bib0005","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lrr.2023.100372_bib0006","first-page":"5","article-title":"Epidemiology of non-Hodgkin's lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.lrr.2023.100372_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.lrr.2023.100372_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminhematol.2015.01.006","article-title":"The histological classification of diffuse large B-cell lymphomas","volume":"52","author":"Xie","year":"2015","journal-title":"Semin. Hematol."},{"issue":"7","key":"10.1016\/j.lrr.2023.100372_bib0009","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.lrr.2023.100372_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.14740\/jh554","article-title":"Unraveling the mystery of gray zone lymphoma in human immunodeficiency virus-seropositive patients: two cases","volume":"9","author":"Ahluwalia","year":"2020","journal-title":"J. Hematol."},{"key":"10.1016\/j.lrr.2023.100372_bib0011","unstructured":"Grey Zone Lymphoma (GZL). Lymphoma Australia. https:\/\/www.lymphoma.org.au\/types-of-lymphoma\/non-hodgkin-lymphoma\/aggressive-fast-growing-b-cell-nhl\/grey-zone-lymphoma-gzl\/. Published May 11, 2022. Accessed November 2, 2022."},{"issue":"4","key":"10.1016\/j.lrr.2023.100372_bib0012","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3324\/haematol.2011.043026","article-title":"Mediastinal gray zone lymphoma","volume":"96","author":"Quintanilla-Martinez","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.lrr.2023.100372_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17474086.2020.1696186","article-title":"Into the gray-zone: update on the diagnosis and classification of a rare lymphoma","volume":"13","author":"Egan","year":"2019","journal-title":"Expert Rev. Hematol."},{"issue":"4","key":"10.1016\/j.lrr.2023.100372_bib0014","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"issue":"26","key":"10.1016\/j.lrr.2023.100372_bib0015","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of Gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.lrr.2023.100372_bib0016","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2016.152256","article-title":"Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association","volume":"102","author":"Sarkozy","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.lrr.2023.100372_bib0017","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.bbmt.2019.12.471","article-title":"Trends and outcomes of gray zone lymphoma in the United States: a population-based registry study","volume":"26","author":"Qasrawi","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"20","key":"10.1016\/j.lrr.2023.100372_bib0018","first-page":"2375","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.lrr.2023.100372_bib0019","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.hoc.2016.07.006","article-title":"Gray zone lymphoma: current diagnosis and treatment options","volume":"30","author":"Pilichowska","year":"2016","journal-title":"Hematol.\/Oncol. Clin."},{"issue":"4","key":"10.1016\/j.lrr.2023.100372_bib0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3324\/haematol.2011.043026","article-title":"Mediastinal gray zone lymphoma","volume":"96","author":"Quintanilla-Martinez","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.lrr.2023.100372_bib0021","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/cancers14030742","article-title":"The grey zones of classic Hodgkin lymphoma","volume":"14","author":"Bosch-Schips","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.lrr.2023.100372_bib0022","first-page":"1563","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"13","key":"10.1016\/j.lrr.2023.100372_bib0023","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational landscape of gray zone lymphoma","volume":"137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.lrr.2023.100372_bib0024","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.lrr.2023.100372_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bjh.14174","article-title":"How I manage patients with grey zone lymphoma","volume":"174","author":"Kritharis","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"17","key":"10.1016\/j.lrr.2023.100372_bib0026","first-page":"3268","article-title":"Integrative analysis reveals selective 9p24. 1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.lrr.2023.100372_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood-2020-137653","article-title":"Nivolumab combined with brentuximab vedotin for relapsed\/refractory mediastinal gray zone lymphoma: primary efficacy and safety analysis of the phase 2 CheckMate 436 study","volume":"136","author":"Santoro","year":"2020","journal-title":"Blood"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048923000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048923000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:39Z","timestamp":1761959319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048923000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"alternative-id":["S2213048923000122"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100372","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gray zone lymphoma: A case report and comprehensive review of literature","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100372"}}